Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder
The USD 16.8 billion (by 2035) financial opportunity within bispecific antibodies market has been analyzed across the following segments:
- Therapeutic Area
- Autoimmune Disorders
- Genetic Disorders
- Hematological Malignancies
- Ophthalmic Disorders
- Skin Cancers
- Solid Tumors
- Mechanism of Action
- Cytokines Retargeting / Neutralization
- Dual Ligands Blocking
- Resistance Factors Co-targeting
- Targeting Tumor Angiogenesis
- T-Cell Retargeting / Activation
- Others
- Target Antigen
- C5-Albumin
- CD20 x CD3
- CD3 x BCMA
- CD3 x CD19
- EGFR x cMET
- EpCAM x CD3
- Factor IXa x Factor X
- gp100 x CD3
- HER2 x HER2
- PD-1 x CTLA-4
- PD-L1 x TGFβ
- TNF-α x HSA
- VEGF x DLL4
- VEGF-A x ANG2
- Antibody Format
- Asymmetric
- Fragments
- Key Players
- Akeso Biopharma
- Alexion
- Amgen
- Genmab
- Immunocore
- Janssen Research & Development
- Linton Pharm
- Merck
- OncXerna Therapeutics
- Pfizer
- Roche
- Taisho Pharmaceutical
- Zymeworks
- Key Geographical Regions
- Asia
- Europe
- North America
- Rest of the World
The Bispecific Antibodies Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:
- Akeso Biopharma
- Alphamab Oncology
- Amgen
- Merck
- Regeneron
- Roche
- Xencor
Table of Contents
- Preface
- Executive Summary
- Introduction
- Market Landscape of Approved and Clinical Therapies
- Market Landscape of Preclinical Therapies
- Key Insights
- Technology Assessment Framework
- Big Pharma Players: Benchmarking Analysis
- Company Profiles
- Partnerships and Collaborations
- Contract Services for Bispecific Antibody Therapeutics
- Clinical Trial Analysis
- Case Study: Regulatory Guidelines for Bispecific Antibodies
- Case Study: Promotional / Marketing Strategies
- Market Forecast and Opportunity Analysis
- SWOT Analysis
- Concluding Remarks
- Executive insights
- Appendix 1: Tabulated data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Exclusive For You!
🚀 Ready to take your business to the next level? Look no further than Walltronix! We're your go-to experts for all things digital, dedicated to helping businesses of all sizes thrive. 🌟 Imagine a future where innovation and creativity reign supreme. That's what we're all about. 🎨 From jaw-dropping design and development to turbocharged SEO services, we've got your digital needs covered. 💻✨ Join us on this exciting journey to digital success! 🌐💼
Walltronix core services encompass:
- Digital & Social Media Marketing
- Website Design & Development
- E-commerce Development
- Native Mobile Applications
- Web & SaaS Applications
- SEO & Backlink Generation
- Content Management
- Blog creation & monetization
Unlocking Your Potential with Walltronix:
Discover a range of Free invaluable tools, thoughtfully crafted to enhance your digital journey:
- Bolt: Website audit & SEO report generator Tool
- The SMS City: Premium WhatsApp & SMS messaging Platform
- Sizzly: Advanced URL shortner, Custom CTA, Bio Pages & much More
- Optimus: Track live website visitors & traffic
- Mosh: Ultimate website widgets & conversion generator
Elevate your digital presence and engage your audience effectively with Walltronix. Join hands with us, and let's shape your digital future together.
Visit Website
Mail Us
WhatsApp Us
Our Portfolios
